
    
      PRP decreases IL-1β, IL-6, IL-8, and TNFα inflammatory genes expression while also reduces
      IL-1β and TNFα inflammatory cytokines production. PRP has also been showed to contain
      interleukin 1 receptor antagonist (IL-1RA), an anti-inflammatory cytokines that suppress IL-6
      secretion.
    
  